Sign inJoin waitlistJoin the waitlist

Jeffrey Holzbeierlein

Vice President and Physician in Chief, The University of Kansas Cancer Center · Olathe Medical Center, Inc

Credentials: · · · · ·

History

Washington University/B-JH/SLCH Consortium
Present

Memorial Sloan Kettering Cancer Center
Urology
Vanderbilt University Medical Center
1996–2001
Univ of Oklahoma Coll of Med
1990–1994

Research

ARCHES: A Randomized, Phase III Study of Androgen Deprivation Therapy With Enzalutamide or Placebo in Men With Metastatic Hormone-Sensitive Prostate Cancer
Journal of Clinical Oncology · 2019 · 981 citations
Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/ASTRO/SUO Guideline
The Journal of Urology · 2017 · Last of 14 authors · 746 citations
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
American Journal Of Pathology · 2004 · First of 12 authors · 454 citations

Eugene Lee
29 papers · 15 as a resident
Sia Daneshmand
22 papers
Yair Lotan
20 papers
JT
J. Thrasher
14 papers
PS
Philippe Spiess
14 papers
TB
Trinity Bivalacqua
14 papers · 2 as a resident
Moben Mirza
13 papers
Todd Morgan
13 papers
AS
Andrew Stephenson
12 papers
Colin Dinney
12 papers
Daniel Barocas
12 papers
Jonathan Wright
12 papers

Clinical trials

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors
Principal investigator · Recruiting
University of Kansas Medical Center
2021–2024
Utilization of PTNS During Office-Based Cystoscopy
Principal investigator · Completed
University of Kansas Medical Center
2020–2021
Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer
Principal investigator · Completed
University of Kansas Medical Center
2017–2018
Soy Derivatives for Control of Hot Flashes in Men on Androgen Deprivation Therapy
Principal investigator · Terminated · Phase 2
University of Kansas Medical Center
2004–2010